Royal Bank of Canada’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Royal Bank of Canada’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-250	Closed	–	–	6760
2015 Q4	$0	Buy	+250	New	+$120	﹤0.01%	6907

Other funds holding BDR

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

AWW

Alan W. Weber $336M AUM 75.94% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Royal Bank of Canada's BDR Position: Q1 2016 in Review

Royal Bank of Canada sold out of Blonder Tongue Laboratories Inc (BDR) in Q1 2016, closing a stake of 250 shares.

Royal Bank of Canada first reported a position in BDR in Q4 2015 and held it in 1 quarter. The position peaked at $0 in Q4 2015. 8 funds tracked by Wall St. Rank hold BDR as of Q1 2016.

Royal Bank of Canada reported no remaining Blonder Tongue Laboratories Inc position as of Q1 2016 after selling out during the quarter.
Royal Bank of Canada sold 250 Blonder Tongue Laboratories Inc shares in Q1 2016.
Royal Bank of Canada first reported a position in Blonder Tongue Laboratories Inc in Q4 2015 and held it in 1 quarter.
Royal Bank of Canada's Blonder Tongue Laboratories Inc position peaked at $0 in Q4 2015.
8 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q1 2016.

Based on Royal Bank of Canada's 13F filing for Q1 2016, filed 16 May 2016.